Hers UK

Hers UK: women's telehealth for weight loss, hair and metabolic health

Hers UK is an online healthcare platform aimed specifically at women, with services centred on weight loss, hair loss and metabolic health. The company presents itself as a personalised care model that combines consultations with clinicians registered in the UK, treatments sent discreetly to the home and continuous monitoring through its app.

The company states that it is registered with the Care Quality Commission (CQC), the body that also regulates NHS services, and states that its clinical protocols are reviewed monthly. It also notes that it has 26 peer-reviewed studies published on its care model and weight outcomes, and that it is part of the global Hims & Hers group.

Areas of care and clinical approach

Hers UK structures its offering around three main areas: weight loss, hair loss and metabolic health. In addition, there is an at-home metabolic test that helps guide the treatment plan based on biological data. The company states that its online questionnaires have been designed by women's health experts and include more than 100 questions to gather the patient's full history.

The clinical approach includes unhurried consultations with professionals trained in the conditions they treat, with the aim of understanding the full picture rather than addressing isolated symptoms. The company states that its treatments go beyond medication and incorporate lifestyle and behavioural changes.

Reported results and scientific backing

According to data published by the company itself, patients lose an average of 16.4% of their body weight in six months, a proportion that, according to Hers, is more likely to be achieved with its programme than in medication-only trials. The company also maintains that 90% of its patients maintain their goal weight after six months and that only 1 in 100 patients cancels monthly due to side effects.

According to the source, these data come from an equivalent programme within the global Hims & Hers group of clinics and from research published in international journals in collaboration with research institutes.

Monitoring, app and ongoing support

The platform includes an app to record weight, symptoms and side effects, and to translate that data into understandable information about the patient's progress. Clinicians can proactively adjust the dose based on those records, balancing health outcomes, treatment efficacy and preparation for lasting results.

Hers UK offers clinical support 24 hours a day, 7 days a week. The service includes an artificial intelligence assistant trained with the team's clinical experience and, when a person is needed, the company states that a clinician responds in less than five minutes. It also carries out proactive reviews to contact the patient before she requests it and helps plan treatment around travel, events or holidays.

Clinical team

The company highlights several professionals on its team. Dr Jessica Shepherd is Hers' global chief medical officer and gynaecologist; Dr Alexandra Davidson is an NHS GP and functional medicine doctor; Dr Alice Pan is clinical director; and Catherine Bell is a dietitian. In their statements, all of them stress the need to listen to patients, offer options beyond a single treatment and address women's health comprehensively, taking into account the interaction between hormones, mental health, nutrition, weight and sleep.

Pricing and treatment model

Hers UK states that its pricing is simple and transparent. When completing the treatment questionnaire, the patient sees a pricing table with the current monthly cost and the possible cost if the plan changes in the future. According to the company, the monthly fee covers medication if prescribed, 24/7 support with regular check-ins, digital tracking tools, expert content and the flexibility to adjust or cancel the plan at any time at no extra cost. The exact long-term price depends on how the treatment evolves and, according to the company, the full cost is always shown before starting.

Treatments are dispensed in regulated pharmacies that comply with the GPhC and the MHRA, and are sent from the pharmacy to the patient's home discreetly. The company states that delivery is next-day.